55 Stocks Moving In Monday's Mid-Day Session

Gainers

• Cocrystal Pharma, Inc. COCP shares surged 162.5% to $1.31 following a licensing agreement the company reached with the Kansas State University Research Foundation. Cocrystal said the agreement with KSURF gives it an exclusive, royalty-bearing right and license to certain antiviral compounds for the treatment of norovirus and coronavirus infections covered by the latter's patents.
• Enlivex Therapeutics Ltd ENLV climbed 66.8% to $15.54 after the company said it will increase its manufacturing capacity for the potential treatment of Coronavirus in Israel.
• NanoViricides, Inc. NNVC shares climbed 44.4% to $9.56 following continued increase in the number of coronavirus cases outside China. Italy now has over 200 confirmed cases in 7 different regions. South Korean officials have reported over 700 cases of coronavirus and Iran has seen 50 deaths from the virus.
• Allied Healthcare Products, Inc. AHPI rose 29.5% to $3.1850.
• Cemtrex, Inc. CETX shares rose 27.3% to $1.77. Cemtrex reported a 500% surge in new orders for the development of VR and AR applications in quarter-to-date.
• ADDvantage Technologies Group, Inc. AEY surged 19.7% to $5.09
• Tocagen Inc. TOCA gained 18.5% to $2.2550 after jumping 111% on Friday.
• Beyond Air, Inc. XAIR rose 18.5% to $7.67.
• China Online Education Group COE gained 18.1% to $27.35.
• NGM Biopharmaceuticals, Inc. NGM surged 17% to $18.89 following a positive clinical data readout. California-based NGM announced positive preliminary top-line results from Cohort 4 of an adaptive Phase 2 study that evaluated the efficacy, safety and tolerability of 1mg aldafermin in patients with biopsy-confirmed non-alcoholic steatohepatitis, or NASH, with stage 2 or 3 liver fibrosis.
• Vir Biotechnology, Inc. VIR gained 16.6% to $18.96 amid the global coronavirus spread. The company recently announced it has identified antibodies that bind to the spike protein 2019-nCoV and is potentially being seen as a coronavirus play.
• IAMGOLD Corporation IAG surged 16.4% to $3.6423 amid a dip in global equities on growing coronavirus fears.
• Alpha Pro Tech, Ltd. APT shares rose 15.5% to $6.59 after climbing more than 9% on Friday.
• Genprex, Inc. GNPX shares jumped 15% to $6.13 after surging around 22% on Friday.
• BOQI International Medical Inc. BIMI climbed 14.2% to $4.1101 after gaining 5.5% on Friday.
• China Jo-Jo Drugstores Inc CJJD jumped 12.9% to $2.02 following an increase in the number of Coronavirus cases.
• Avadel Pharmaceuticals plc AVDL gained 12.2% to $10.55.
• Brainstorm Cell Therapeutics Inc. BCLI surged 11.1% to $7.64.
• Lianluo Smart Limited LLIT rose 10.7% to $0.7269. Lianluo Smart shares dropped around 23% on Friday after the company priced a 3.5 million share common stock offering at $0.70 per share.
• Eldorado Gold Corporation EGO gained 9.9% to $10.91 amid a dip in global equities on growing coronavirus fears.
• Cleveland BioLabs, Inc. CBLI rose 9.6% to $2.18.
• Inovio Pharmaceuticals, Inc. INO rose 8.6% to $4.07. Shares of flu shot manufacturer stocks climbed following an increase in non-Chinese Coronavirus cases.
• GSX Techedu Inc. GSX gained 8.5% to $46.33.
• BlueLinx Holdings Inc. BXC climbed 8.6% to $16.75. BlueLinx shares dipped around 21% on Friday after the company said it was “not aware’ of any tender offer from Bluefin Acquisitions.
• Novavax, Inc. NVAX rose 8.3% to $8.35. Shares of flu shot manufacturer stocks surged following an increase in non-Chinese Coronavirus cases.
• Harmony Gold Mining Company Limited HMY rose 7.6% to $4.4439 after climbing 12.5% on Friday.
• Vaxart Inc VXRT climbed 5.5% to $1.1494 following an increase in the reported number of Coronavirus cases.

Check out these big penny stock gainers and losers

Losers

• Aethlon Medical, Inc. AEMD shares dipped 16.9% to $2.1450.
• Tiziana Life Sciences PLC TLSA shares dropped 16.4% to $1.68.
• Aspen Aerogels, Inc. ASPN shares declined 16.2% to $8.23.
• Epizyme, Inc. EPZM tumbled 16.2% to $20.84 after the company reported a loss for its fourth quarter.
• Kosmos Energy Ltd. KOS dipped 15.9% to $4.185. Kosmos Energy reported a Q4 loss of $0.09 per share.
• Lumber Liquidators Holdings, Inc. LL fell 15.4% to $8.84. Lumber Liquidators is expected to report quarterly results on Tuesday before the opening bell. Heading into the earnings report, shares of the company have been up 8 straight sessions and gained more than 40%.
• Platinum Group Metals Ltd. PLG dropped 15.1% to $2.3336.
• Borr Drilling Limited BORR fell 15% to $3.11.
• Ballard Power Systems Inc. BLDP shares fell 14.9% to $11.20.
• Nabors Industries Ltd. NBR dipped 14% to $1.98. Stephens & Co. lowered the price target on the stock from $3 to $2.5.
• Carter's, Inc. CRI fell 13% to $96.33 after the company reported downbeat Q4 earnings and issued weak FY20 earnings forecast. The company also announced a $500 million buyback program.
• The E.W. Scripps Company SSP dropped 13% to $11.80.
• Celldex Therapeutics, Inc. CLDX shares slipped 13% to $2.67.
• Farfetch Limited FTCH dropped 13% to $10.69.
• Guess', Inc. GES fell 12.9% to $18.58 amid continued spread of coronavirus including notable upticks in Iran and Italy.
• Dorman Products, Inc. DORM tumbled 12.8% to $66.90 after the company reported downbeat Q4 results and issued weak FY20 earnings outlook.
• Fossil Group, Inc. FOSL declined 12.7% to $5.24 amid the continued spread of the coronavirus in and outside of China. The coronavirus has weighed on economic outlook and impacted stocks across sectors, including discretionary goods.
• Strongbridge Biopharma plc SBBP dropped 12.7% to $2.845.
• Valaris plc VAL dipped 12.5% to $3.6750.
• Ryanair Holdings plc RYAAY fell 12.2% to $79.62.
• At Home Group Inc. HOME dropped 11.8% to $6.30.
• Clovis Oncology, Inc. CLVS fell 11.5% to $9.74.
• Daseke, Inc. DSKE dropped 11.5% to $3.76.
• Callon Petroleum Company CPE slipped 11.4% to $2.525.
• FuelCell Energy, Inc. FCEL shares fell 10.3% to $2.26.
• Plug Power Inc. PLUG fell 9.7% to $5.03.
• JinkoSolar Holding Co., Ltd. JKS shares fell 6.6% to $25.42.
• Virgin Galactic Holdings Inc SPCE dropped 6% to $31.84 potentially due to Barron's calling the stock's recent climb in share price 'Hype.'